Agenus | AGEN - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
AbbVie USD 9.39B 4.16B 2026-03
Agenus USD 35M 32M 2026-03
Amgen USD 12.04B 2.91B 2026-03
AstraZeneca USD 7.56B 1.85B 2026-03
Bristol-Myers Squibb USD 9.57B 635M 2026-03
Celldex Therapeutics USD 35.73M 6.86M 2026-03
CSL USD 2.16B 633M 2025-06
Eli Lilly USD 5.28B 1.99B 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
GlaxoSmithKline GBP 3.44B 292M 2026-03
Glaxosmithkline GBP 3.3B 303M 2025-09
Incyte USD 4.02B 435.22M 2026-03
Intrexon USD 9.34M 1.77M 2024-06
J&J USD 21.69B 1.98B 2026-03
Jiangsu Hengrui CNY 40.96B 591.41M 2025-12
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
MacroGenics USD 66.52M 9.3M 2026-03
Merck EUR 2.33B 77M 2025-12
Merck USD 5.33B 9.24B 2026-03
Northwest Biotherapeutics USD 4.56M 244K 2025-09
Novartis USD 6.88B 4.56B 2026-03
Novavax USD 228.36M 12.27M 2026-03
Pfizer USD 1.7B 561M 2026-03
Regeneron Pharmaceuticals USD 2.96B 15.9B 2026-03
Rigel Pharmaceuticals USD 48.53M 4.87M 2025-09
Sangamo BioSciences USD 38.34M 13.16M 2025-06
Veracyte USD 263.14M 99.44M 2026-03